SparklingNavigator24
11 minutes ago
Adapt Therapeutics plc has one drug approved in the US. The drug, TECELRA® (afamitresgene autoleucel), is a T-cell therapy approved for the treatment of adults with unresectable or metastatic synovial sarcoma who have received prior chemotherapy and are HLA-A02:01P, -A02:02P, -A02:03P, or -A02:06P p